CRISPR-Cas9
BackgroundHighlights
CRISPR-Cas9 has recently emerged as a promising system for multiplexed genome editing as well as epigenome and transcriptome perturbation. Due to its specificity, ease of use and highly modular programmable nature, it has been widely adopted for a variety of applications such as genome editing, transcriptional inhibition and activation, genetic screening, DNA localization imaging, and many more. In this review, we will discuss non-editing applications of CRISPR-Cas9 for transcriptome perturbation, metabolic engineering, and synthetic biology.[1] Transcriptional regulation with CRISPR-Cas9![]() Cas9 is a key protein of bacterial Type II CRISPR adaptive immune system. In its native context, Cas9 is an RNA-guided endonuclease that is responsible for targeted degradation of the invading foreign DNA–plasmids and phages. Cas9 is directed to its DNA targets by forming a ribonucleoprotein complex with two small non-coding RNAs: CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) (Figure 1a). By elegant engineering, crRNA and tracrRNA can be joined end-to-end and transcribed as a single guide RNA (sgRNA) that too efficiently directs Cas9 protein to DNA targets encoded within the guide sequence of sgRNA [2]. The optimal DNA target of the complex is determined by a Watson–Crick base pairing of a short ∼20-nt sequence within sgRNA (within the crRNA in wild-type), termed the guide sequence, adjacent to a few nucleotide long conserved motif recognized directly by Cas9 protein (protospacer adjacent motif, PAM) [2]. Despite this, a few mismatches between guide sequence and target DNA can be tolerated [2], more so within the 5’ proximal position of the guide sequence. Cas9 nuclease can be converted into deactivated Cas9 (dCas9), an RNA-programmable DNA-binding protein, by mutating two key residues within its nuclease domains (Figure 1b) [1][2]. Examples of 3D structures of crRNACrystal structure of a CRISPR RNA-guided surveillance complex, Cascade, bound to a ssDNA target[3]The . The body is formed by a helical filament of six Cas7 subunits (Cas7.1 to 7.6) wrapped around the crRNA guide, with a head-to-tail dimer of Cse2 (Cse2.1 and Cse2.2) at the belly. Cas6e and the 3′ handle of crRNA cap the Cas7 filament at the head while Cas5 and the 5′ handle cap the tail. The N-terminal base of Cse1 is positioned at the tail of the filament; the C-terminal four-helix bundle contacts Cse2.2. The ssDNA target is juxtaposed to the guide region of the crRNA in a groove formed by the Cas7 filament, the four-helix bundle of Cse1, and the Cse2 dimer.
The do not twist around one another in a helix, but instead adopt an underwound ribbon-like structure reminiscent of a ladder. The 5′ and 3′ ends of the curved target strand are ~102Å apart, roughly the length of straight B-form dsDNA with an identical sequence (~107 Å). The crRNA (green) and ssDNA target (orange) are displayed in a spheres representation. Underwinding is facilitated by (ribbon representation of the crRNA and ssDNA). . Disrupted RNA and DNA nucleotides are colored red and blue, respectively. Structure of the Cas7 subunit.Within Cascade, the , with a pitch of ~135Å, around the guide target hybrid. The filament is arranged such that the . . Stabilization of the guide-target hybrid by Cas7, Cse1, and Cse2.. 5-bp segment is colored red. Extensive contacts between the guide region of the crRNA and the Cas7 filament bury a large portion of the crRNA backbone, leaving the bases solvent-exposed. The absence of direct contacts between protein side chains and bases of the crRNA explains the lack of sequence specificity by Cascade for the guide sequence. . The DNA target has been removed for clarity. Intercalation by Met166 from Cas7 is highlighted. , while the . Of note, the . . Each displaced RNA nucleotide adopts the syn conformation, is similarly positioned above the backbone of the downstream RNA, and is contacted by . Overview of the . The proteins are represented as rockets, the DNA as a surface. The positions of the disrupted DNA nucleotides (royal blue) are indicated. Interactions capping the tail of Cascade. The structure of Cascade reveals that Cas5 is structurally related to Cas7, as it consists of a palm(residues 1 to 78 and 115 to 224) and a thumb (residues 79 to 114) domain, but lacks a fingers domain. . Close-up view of the . Crystal structure of E. coli Cascade bound to a PAM-containing dsDNA target at 2.45 angstrom resolution[4].
|
|
ReferencesReferences
- ↑ 1.0 1.1 1.2 1.3 Didovyk A, Borek B, Tsimring L, Hasty J. Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications. Curr Opin Biotechnol. 2016 Aug;40:177-84. doi: 10.1016/j.copbio.2016.06.003. Epub, 2016 Jun 23. PMID:27344519 doi:http://dx.doi.org/10.1016/j.copbio.2016.06.003
- ↑ 2.0 2.1 2.2 2.3 Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012, Jun 28. PMID:22745249 doi:http://dx.doi.org/10.1126/science.1225829
- ↑ Mulepati S, Heroux A, Bailey S. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science. 2014 Aug 14. pii: 1256996. PMID:25123481 doi:http://dx.doi.org/10.1126/science.1256996
- ↑ Hayes RP, Xiao Y, Ding F, van Erp PB, Rajashankar K, Bailey S, Wiedenheft B, Ke A. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli. Nature. 2016 Feb 25;530(7591):499-503. doi: 10.1038/nature16995. Epub 2016 Feb, 10. PMID:26863189 doi:http://dx.doi.org/10.1038/nature16995